1. Home
  2. GERN vs COUR Comparison

GERN vs COUR Comparison

Compare GERN & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.26

Market Cap

808.3M

Sector

Health Care

ML Signal

HOLD

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.46

Market Cap

932.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
COUR
Founded
1990
2012
Country
United States
United States
Employees
258
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
808.3M
932.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GERN
COUR
Price
$1.26
$5.46
Analyst Decision
Hold
Buy
Analyst Count
3
15
Target Price
$2.17
$10.53
AVG Volume (30 Days)
13.9M
6.0M
Earning Date
05-06-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.22
EPS
N/A
N/A
Revenue
N/A
$757,500,000.00
Revenue This Year
$26.91
$9.43
Revenue Next Year
$43.75
$6.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.04
52 Week Low
$1.04
$5.00
52 Week High
$2.01
$13.56

Technical Indicators

Market Signals
Indicator
GERN
COUR
Relative Strength Index (RSI) 34.40 47.18
Support Level $1.22 $5.09
Resistance Level $1.29 $6.41
Average True Range (ATR) 0.06 0.31
MACD -0.00 -0.00
Stochastic Oscillator 21.15 52.16

Price Performance

Historical Comparison
GERN
COUR

About GERN Geron Corporation

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

Share on Social Networks: